Skip to main content
Erschienen in: Annals of Surgical Oncology 5/2016

09.09.2016 | Gastrointestinal Oncology

Risk Stratification According to the Total Number of Factors That Meet the Indication Criteria for Radical Lymph Node Dissection in Patients with Early Gastric Cancer at Risk for Lymph Node Metastasis

verfasst von: Katsutoshi Shoda, Daisuke Ichikawa, Tomohiro Arita, Toshiyuki Kosuga, Hirotaka Konishi, Ryo Morimura, Yasutoshi Murayama, Shuhei Komatsu, Atsushi Shiozaki, Yoshiaki Kuriu, Hisashi Ikoma, Masayoshi Nakanishi, Hitoshi Fujiwara, Kazuma Okamoto, Eigo Otsuji

Erschienen in: Annals of Surgical Oncology | Sonderheft 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Extended indications for endoscopic resection for early gastric cancer (EGC) have been widely accepted. However, according to current guidelines, additional gastrectomy with lymph node dissection (LND) is recommended for patients proven to have potential risks of lymph node metastasis (LNM) on histopathological findings. The aim of this study was to elucidate the risk stratification of outcome and LNM according to the number of factors that meet the inclusion criteria for radical LND for possible LNM (LNM risk factors) in patients with negative endoscopic resection margin.

Methods

We enrolled 511 EGC patients whose tumors did not meet the absolute or extended indications for endoscopic resection, and investigated the risk stratification of prognosis and LNM according to the total number of LNM risk factors.

Results

Recurrence-free and overall survival rates were significantly higher in patients with fewer LNM risk factors for surgical indication (p = 0.0274 and 0.0002, respectively; log-rank test), and the total number of LNM risk factors and frequency of LNM were significantly correlated (p < 0.0001; Kruskal–Wallis test). When only one LNM risk factor was satisfied, the LNM ratio was 0.58 % (1/173, 95 % confidence interval 0.01–3.18).

Conclusion

The present study suggested the possibility of using further minimally invasive treatment strategies based on the total number of LNM risk factors.
Literatur
1.
Zurück zum Zitat Yamada S, Doyama H, Yao K, et al. An efficient diagnostic strategy for small, depressed early gastric cancer with magnifying narrow-band imaging: a post hoc analysis of a prospective randomized controlled trial. Gastrointest Endosc. 2014;79:55–63.CrossRefPubMed Yamada S, Doyama H, Yao K, et al. An efficient diagnostic strategy for small, depressed early gastric cancer with magnifying narrow-band imaging: a post hoc analysis of a prospective randomized controlled trial. Gastrointest Endosc. 2014;79:55–63.CrossRefPubMed
2.
Zurück zum Zitat Tao G, Xing-Hua L, Ai-Ming Y, et al. Enhanced magnifying endoscopy for differential diagnosis of superficial gastric lesions identified with white-light endoscopy. Gastric Cancer. 2014;17:122–9.CrossRefPubMed Tao G, Xing-Hua L, Ai-Ming Y, et al. Enhanced magnifying endoscopy for differential diagnosis of superficial gastric lesions identified with white-light endoscopy. Gastric Cancer. 2014;17:122–9.CrossRefPubMed
3.
Zurück zum Zitat Oda I, Saito D, Tada M, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer. 2006; 9:262–70.CrossRefPubMed Oda I, Saito D, Tada M, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer. 2006; 9:262–70.CrossRefPubMed
4.
Zurück zum Zitat Koeda K, Nishizuka S, Wakabayashi G, et al. Minimally invasive surgery for gastric cancer: the future standard of care. World J Surg. 2011;35:1469–77.CrossRefPubMed Koeda K, Nishizuka S, Wakabayashi G, et al. Minimally invasive surgery for gastric cancer: the future standard of care. World J Surg. 2011;35:1469–77.CrossRefPubMed
5.
Zurück zum Zitat Tanabe S, Ishido K, Higuchi K, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a retrospective comparison with conventional endoscopic resection in a single center. Gastric Cancer. 2014;17:130–6.CrossRefPubMed Tanabe S, Ishido K, Higuchi K, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a retrospective comparison with conventional endoscopic resection in a single center. Gastric Cancer. 2014;17:130–6.CrossRefPubMed
6.
Zurück zum Zitat Lin JP, Zhang YP, Xue M, et al. Endoscopic submucosal dissection for early gastric cancer in elderly patients: a meta-analysis. World J Surg Oncol. 2015;13:293.CrossRefPubMedPubMedCentral Lin JP, Zhang YP, Xue M, et al. Endoscopic submucosal dissection for early gastric cancer in elderly patients: a meta-analysis. World J Surg Oncol. 2015;13:293.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Facciorusso A, Antonino M, Di Maso M, et al. Endoscopic submucosal dissection versus endoscopic mucosal resection for early gastric cancer: a meta-analysis. World J Gastrointest Endosc. 2014;6:555–63.CrossRefPubMedPubMedCentral Facciorusso A, Antonino M, Di Maso M, et al. Endoscopic submucosal dissection versus endoscopic mucosal resection for early gastric cancer: a meta-analysis. World J Gastrointest Endosc. 2014;6:555–63.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Gotoda T, Jung HY. Endoscopic resection (endoscopic mucosal resection/endoscopic submucosal dissection) for early gastric cancer. Dig Endosc. 2013;1:55–63.CrossRef Gotoda T, Jung HY. Endoscopic resection (endoscopic mucosal resection/endoscopic submucosal dissection) for early gastric cancer. Dig Endosc. 2013;1:55–63.CrossRef
9.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef
10.
Zurück zum Zitat Lee H, Yun WK, Min BH, et al. A feasibility study on the expanded indication for endoscopic submucosal dissection of early gastric cancer. Surg Endosc. 2011;25:1985–93.CrossRefPubMed Lee H, Yun WK, Min BH, et al. A feasibility study on the expanded indication for endoscopic submucosal dissection of early gastric cancer. Surg Endosc. 2011;25:1985–93.CrossRefPubMed
11.
Zurück zum Zitat Peng LJ, Tian SN, Lu L, et al. Outcome of endoscopic submucosal dissection for early gastric cancer of conventional and expanded indications: systematic review and meta-analysis. J Dig Dis. 2015;16:67–74.CrossRefPubMed Peng LJ, Tian SN, Lu L, et al. Outcome of endoscopic submucosal dissection for early gastric cancer of conventional and expanded indications: systematic review and meta-analysis. J Dig Dis. 2015;16:67–74.CrossRefPubMed
12.
Zurück zum Zitat Ahn JY, Jung HY, Choi KD, et al. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. Gastrointest Endosc. 2011;74:485–93.CrossRefPubMed Ahn JY, Jung HY, Choi KD, et al. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. Gastrointest Endosc. 2011;74:485–93.CrossRefPubMed
13.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef
14.
Zurück zum Zitat Sobin LH, Wittekind CH, Gospodarowicz M (eds). TNM classification of malignant tumors. 7th ed. New York: Wiley; 2009. pp. 73–7. Sobin LH, Wittekind CH, Gospodarowicz M (eds). TNM classification of malignant tumors. 7th ed. New York: Wiley; 2009. pp. 73–7.
15.
Zurück zum Zitat Hölscher AH, Drebber U, Mönig SP, et al. Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration. Ann Surg. 2009;250:791–7.CrossRefPubMed Hölscher AH, Drebber U, Mönig SP, et al. Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration. Ann Surg. 2009;250:791–7.CrossRefPubMed
16.
Zurück zum Zitat Yajima H, Omura N, Takahashi N, et al. Additional gastrectomy after endoscopic mucosal resection for early gastric cancer. Int Surg. 2015;100:169–72.CrossRefPubMedPubMedCentral Yajima H, Omura N, Takahashi N, et al. Additional gastrectomy after endoscopic mucosal resection for early gastric cancer. Int Surg. 2015;100:169–72.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Koide N, Takeuchi D, Suzuki A, et al. Additional gastrectomy after endoscopic submucosal dissection for early gastric cancer patients with comorbidities. Int J Surg Oncol. 2012;2012:379210.PubMedPubMedCentral Koide N, Takeuchi D, Suzuki A, et al. Additional gastrectomy after endoscopic submucosal dissection for early gastric cancer patients with comorbidities. Int J Surg Oncol. 2012;2012:379210.PubMedPubMedCentral
18.
Zurück zum Zitat Kondo A, de Moura EG, Bernardo WM, et al. Endoscopy versus surgery in the treatment of early gastric cancer: systematic review. World J Gastroenterol. 2015; 21:13177–87.CrossRefPubMedPubMedCentral Kondo A, de Moura EG, Bernardo WM, et al. Endoscopy versus surgery in the treatment of early gastric cancer: systematic review. World J Gastroenterol. 2015; 21:13177–87.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Oda I, Gotoda T, Sasako M, et al. Treatment strategy after non-curative endoscopic resection of early gastric cancer. Br J Surg. 2008; 95:1495–500.CrossRefPubMed Oda I, Gotoda T, Sasako M, et al. Treatment strategy after non-curative endoscopic resection of early gastric cancer. Br J Surg. 2008; 95:1495–500.CrossRefPubMed
20.
Zurück zum Zitat Lee JH, Kim JH, Kim DH, et al. Is surgical treatment necessary after non-curative endoscopic resection for early gastric cancer? J Gastric Cancer. 2010;10:182–7.CrossRefPubMedPubMedCentral Lee JH, Kim JH, Kim DH, et al. Is surgical treatment necessary after non-curative endoscopic resection for early gastric cancer? J Gastric Cancer. 2010;10:182–7.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Park CH, Shin S, Park JC, et al. Long-term outcome of early gastric cancer after endoscopic submucosal dissection: expanded indication is comparable to absolute indication. Dig Liver Dis. 2013;45:651–6.CrossRefPubMed Park CH, Shin S, Park JC, et al. Long-term outcome of early gastric cancer after endoscopic submucosal dissection: expanded indication is comparable to absolute indication. Dig Liver Dis. 2013;45:651–6.CrossRefPubMed
22.
Zurück zum Zitat Hall BL, Hamilton BH, Richards K, et al. Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals. Ann Surg. 2009;250:363–76.PubMed Hall BL, Hamilton BH, Richards K, et al. Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals. Ann Surg. 2009;250:363–76.PubMed
23.
Zurück zum Zitat Kurita N, Miyata H, Gotoh M, et al. Risk model for distal gastrectomy when treating gastric cancer on the basis of data from 33,917 Japanese patients collected using a nationwide web-based data entry system. Ann Surg. 2015;262:295–303.CrossRefPubMed Kurita N, Miyata H, Gotoh M, et al. Risk model for distal gastrectomy when treating gastric cancer on the basis of data from 33,917 Japanese patients collected using a nationwide web-based data entry system. Ann Surg. 2015;262:295–303.CrossRefPubMed
Metadaten
Titel
Risk Stratification According to the Total Number of Factors That Meet the Indication Criteria for Radical Lymph Node Dissection in Patients with Early Gastric Cancer at Risk for Lymph Node Metastasis
verfasst von
Katsutoshi Shoda
Daisuke Ichikawa
Tomohiro Arita
Toshiyuki Kosuga
Hirotaka Konishi
Ryo Morimura
Yasutoshi Murayama
Shuhei Komatsu
Atsushi Shiozaki
Yoshiaki Kuriu
Hisashi Ikoma
Masayoshi Nakanishi
Hitoshi Fujiwara
Kazuma Okamoto
Eigo Otsuji
Publikationsdatum
09.09.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe Sonderheft 5/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5553-0

Weitere Artikel der Sonderheft 5/2016

Annals of Surgical Oncology 5/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.